LINEZOLID INJECTION
As listed in the register: LINEZOLID INJECTION
2 mg · solution
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Linezolid
- Made by
- Fresenius Kabi Canada Ltd
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Linezolid). It describes the substance, not this exact product.
Linezolid is an antibacterial drug [see Microbiology ( 12.4 ) ].
Linezolid is primarily metabolized by oxidation of the morpholine ring, which results in two inactive ring-opened carboxylic acid metabolites: the aminoethoxyacetic acid metabolite (A), and the hydroxyethyl glycine metabolite (B).
The time to reach the maximum concentration is delayed from 1.5 hours to 2.2 hours and C max is decreased by about 17% when high fat food is given with linezolid.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-03
Safety of the active substance
From the US prescribing label for the same active substance (Linezolid). It describes the substance, not this exact product.
- Known hypersensitivity to linezolid or any of the other product components.
- ( 4.1 ) Patients taking any monoamine oxidase inhibitors (MAOI) or within two weeks of taking an MAOI.
- ( 4.2 ) 4.1 Hypersensitivity Linezolid formulations are contraindicated for use in patients who have known hypersensitivity to linezolid or any of the other product components. 4.2 Monoamine Oxidase Inhibitors Linezolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g., phenelzine, isocarboxazid) or within two weeks of taking any such medicinal product.
Most common adverse reactions (>5% of adult and/or pediatric patients treated with Linezolid) include: diarrhea, vomiting, headache, nausea, and anemia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Fresenius Kabi Canada Ltd |
|---|---|
| Active substance | Linezolid |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 2 mg |
| Form | solution |
| Classification | J01XX08 · Antibiotics, antivirals and antifungals taken into the body |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02430827 |
| DPD drug code | 91526 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution5 products
2 mg5
2 mg · 5 companies
- Auro Pharma Inc
- Eugia Pharma Inc.
- Fresenius Kabi Canada Ltd · this page
- Jamp Pharma Corporation
- Pharmaris Canada Inc
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.